The Lung Cancer Research Foundation and Free to Breathe announced a merger to make an even greater impact on closing the funding gap for lung cancer research. The New York State Attorney General approved the required merger documentation on Sept. 30.
In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
